Pulmonary embolism in a patient with pernicious anemia and hyperhomocysteinemia

Chest

Volumn 122, Issue 4, 2002, Pages 1487-1488

  Caldera, Angel ^a   Mora, Jorge ^a   Kotler, Morris ^a   Eiger, Glenn ^a  

^a ALBERT EINSTEIN MEDICAL CENTER   (United States)

Author keywords

Cobalamin; Hyperhomocysteinemia; Pernicious anemia; Prothrombin gene variant; Pulmonary embolism; Thrombophilia

Indexed keywords

ANTICOAGULANT AGENT; COBALAMIN; FOLIC ACID; HEPARIN; PROTHROMBIN; PYRIDOXINE;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; ATAXIA; CASE REPORT; CLINICAL FEATURE; DRUG MEGADOSE; FEMALE; FOLLOW UP; GENE MUTATION; HUMAN; HYPERHOMOCYSTEINEMIA; LUNG EMBOLISM; MEDICAL EXAMINATION; PERNICIOUS ANEMIA; PRIORITY JOURNAL; SYNCOPE; TREATMENT OUTCOME;

EID: 0036428885     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.122.4.1487     Document Type: Article

References (6)

1. Savage D, Lindenbaum J, Allen R. Sensitivity of serum methylmalonic acid and total homocysteine determinations for diagnosing cobalamin and folate deficiency. Am J Med 1994; 96:239-246
2. Toh BH, van Driel IR, Gleeson PA. Pernicious anemia. N Engl J Med 1997; 337:1441-1448
3. Alpert MA. Homocyst(e)ine, atherosclerosis, and thrombosis. South Med J 1999; 92:858-865
4. Pruth R, Tefferi A. Pernicious anemia revisited. Mayo Clin Proc 1994; 69:144-150
5. Kuzminski AM, Del Giacco EJ, Allen RH, et al. Effective treatment of cobalamin deficiency with oral cobalamin. Blood 1998; 92:1192-1198
6. Eichinger S, Minar E, Hirschl M, et al. The risk of early recurrent venous thromboembolism after oral anticoagulant therapy in patients with the G20210A transition in the prothrombin gene. Thromb Haemost 1999; 81:14-18